Brief: FDA Approves Astellas' Vyloy For A Type Of Gastroesophageal Junction Adenocarcinoma
18/10/2024 17:23
Oct 18 (Reuters) - FDA
* FDA APPROVES ASTELLAS'S VYLOY- WEBSITE
* FDA: APPROVES ASTELLAS' VYLOY FOR A TYPE OF
GASTROESOPHAGEAL
JUNCTION ADENOCARCINOMA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn